Cage Bio Inc.

This study tested a new ointment called CGB-500 for treating atopic dermatitis (eczema) in people aged 12 and older. Participants applied the ointment and a comparison drug to different skin areas twice daily for four weeks. The goal was to see if CGB-500 reduces eczema severity …

This study tested whether a new ointment called CGB-500, containing the drug tofacitinib, can safely improve eczema symptoms. 180 people aged 12 and older used the ointment or a placebo daily for 8 weeks. Researchers tracked skin clearing and itching to see if the treatment works…